Delivery Order SPE2DB20D3103-SPE2DB25FL5D4

Award Date 10/31/24
Potential Completion Date 11/1/24
Potential Value $5.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,567,155,753 units of Lidocaine 5% Patch 30s, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract has a ceiling value of $3,873.10 and is a Firm Fixed Price Delivery Order, with a final completion date of February 5, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award, valued at $4,939.84, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order for 4,563,216,246 units of Lidocaine 5% Patch 30s, a pharmaceutical product. The contract has an ultimate completion date of January 3, 2024 and is a firm fixed-price type contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,568,154,628 units of Lidocaine 5% Patch 30s. The contract has a ceiling value of $18,317.10 and a period of performance through May 7, 2025. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor on this award, which is a part...
This federal contract award is for the delivery of Lidocaine 5% Patches to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 10, 2024 with a ceiling value of $20,466.17. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 11, 2024. There is no set-aside...
This federal contract award is for the supply of Lidocaine 5% Patch 30s to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, the Corporate Office Division of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a Delivery Order with a Firm Fixed Price of $2,364.74 and a completion date of May 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Lidocaine 5% Patch 30s medical products to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on May 21, 2024, with a ceiling value of $2,666.94. The contract is a delivery order with a firm fixed price, and the ultimate completion date is May 22, 2024. This contract is not a set-aside award....
This federal contract award, valued at $4,664.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566121260 - Lidocaine 5% Patch 30s, with a completion date of October 17, 2024. The award is a Delivery Order under a Firm Fixed Price contract type. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Lidocaine 5% Patch 30s. The award, valued at $4,071.45, was made by the Defense Logistics Agency (DLA) on January 7, 2025, with a completion date of January 8, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of Lidocaine 5% Patches to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 26, 2024, with a ceiling value of $1,055.16. The contract is a Firm Fixed Price Delivery Order, with a period of performance through February 27, 2024. There is no set-aside designation for this...
This federal contract award is for the delivery of Lidocaine 5% Patch 30s medical supplies, with a total ceiling value of $45,047.39. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order type with a Firm Fixed Price pricing structure, and the ultimate completion date is June 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FL5D4
    Delivery Order

This federal contract award is for the delivery of 4,566,293,333 units of Lidocaine 5% Patch 30s to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, on October 31, 2024, with a ceiling value of $5,302.97 and a completion date of November 1, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider registered in the System for Award Management (SAM.gov) since 2002. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific contract award does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 12:30 PM